Agoracom Blog Home

Posts Tagged ‘CBD’

North Bud Farms Inc. $NBUD.ca – #Cannabis industry expects bump in sales for #Canada Day long weekend $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 2:00 PM on Thursday, June 27th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE

—————

Cannabis industry expects bump in sales for Canada Day long weekend

  • Canada Day long weekend is no longer mostly the preserve of the liquor industry, say some of the country’s cannabis retailers.
  • More of the pie for that flag-waving party is being carved out by legal pot sellers as the first post-legalization national birthday approaches, says an online cannabis information resource.

By: Bill Kaufmann

The Canada Day long weekend is no longer mostly the preserve of the liquor industry, say some of the country’s cannabis retailers.

More of the pie for that flag-waving party is being carved out by legal pot sellers as the first post-legalization national birthday approaches, says an online cannabis information resource.

A survey commissioned by Leafly Canada suggests 25 per cent of Alberta adults plan to embark on a cannabis buzz this long weekend, among the highest in the country.

“That’s one in four compared to one in five (nationally),” said Jo Vos, managing director of Leafly Canada, which commissioned the poll of 1,513 people conducted last week by Maru/Blue.

That’s due largely to the proliferation of pot shops in Alberta that now number up to 136, leading the nation by a wide margin, she said.

“Alberta and Atlantic Canada are leading the country in plans to consume this weekend,” said Vos.

Among millennials surveyed — those aged 22 to 37 — a whopping 33 per cent said they plan to toke up or consume edibles on Canada’s 152nd anniversary weekend.

The latest Statistics Canada figures on cannabis consumption suggest 15 per cent of Canadians reported using pot in the past three months, with 19 per cent planning to consume it over the next three months.

“That was a similar percentage to what was reported before legalization,” states StatsCan.

Those numbers rise to 33 per cent among those aged 18 to 24.

Cannabis information clearing house Leafly is confident legalization is pushing cannabis use into the mainstream when weekends approach, said Vos.

“We believe consumption patterns will continue to shift and there’s a broader awareness of cannabis as an option,” she said, adding those follow the lines of booze consumption.

“We know there are behaviour patterns very similar to alcohol in the lead-up to weekends.”

There are even “very compelling” indications that cannabis could displace some alcohol use, added Vos.

It was illegal but now there’s a freedom,Mark Goliger

Some statistics on alcohol sales in Canada show they haven’t decreased since pot legalization, but some predict that might happen when cannabis-infused beverages come on the market at year’s end.

Vos acknowledged marketing the newly legalized product is a much tougher task than that facing the alcohol industry, whose wares can be promoted openly on a host of platforms, including newspaper ads and street signage.

Legalization has grown Canadian cannabis demand “but not exponentially,” said Mark Goliger, CEO of National Access Cannabis (NAC), which operates 15 stores in Alberta.

But he said the first summer long weekend following prohibition’s end will likely see a spike in people consuming pot, and those who do should feel no stigma.

“It was illegal but now there’s a freedom,” said Goliger.

“Long weekends are a time for people to relax and enjoy more of everything, whether it’s food, friends, drinks, cannabis and, hopefully, sunshine.”

NAC recently announced revenues of $40 million since legalization, through its NewLeaf Cannabis stores in Alberta and other outlets in Manitoba and Saskatchewan.

“We’d love to have been further ahead but with the (now-ended) moratorium on new stores in Alberta, supply problems, with Ontario going to a lottery system for new stores and B.C. not going as fast as we’d like, it’s impacted things,” he said.

Cannabis retailers expect to sell plenty of the green stuff on the first Canada Day long weekend since legalization.Ryan Remiorz / THE CANADIAN PRESS

Source: https://calgarysun.com/cannabis/cannabis-business/cannabis-industry-eyes-long-weekend-sales-with-survey-claiming-25-usage-rate/wcm/2f66cd9e-628c-421c-bfec-e1d8da91fa9d

Marijuana Company of America’s $MCOA #hempSMART™ Brand Continues European Expansion with Netherlands Launch $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:30 AM on Thursday, June 27th, 2019
15233 mcoa
  • Continued the expansion of its wholly owned subsidiary, hempSMART, Ltd., into Europe, with its latest launch in the Netherlands.
  • As a result of the positive feedback received during its United Kingdom launch in March, the Company made a strategic decision to offer its hempSMART™ CBD product line and expand its European footprint further by holding an event on June 15, 2019, in the Netherlands.

ESCONDIDO, Calif., June 27, 2019 — via NetworkWire – MARIJUANA COMPANY OF AMERICA, INC. (“MCOA” or the “Company”) (OTCQB: MCOA), an innovative hemp and cannabis corporation, has continued the expansion of its wholly owned subsidiary, hempSMART, Ltd., into Europe, with its latest launch in the Netherlands.

As a result of the positive feedback received during its United Kingdom launch in March, the Company made a strategic decision to offer its hempSMART™ CBD product line and expand its European footprint further by holding an event on June 15, 2019, in the Netherlands.

“The Netherlands launch was a complete success, with people traveling from other parts of Europe to witness the excitement around our hempSMART™ CBD product line,” said Mr. Ian Harvey, Global Sales Director of hempSMART, Ltd. “The event featured our CEO, Don Steinberg, unveiling our wellness products via video link and educating people about the benefits of our prime quality botanical ingredients. Our products sold out at the end of the event, and we engaged new marketing associates for hempSMART™ as evangelists to the brand that will help spread our vision.”

“Our high-quality CBD products combined with our compilation of highly knowledgeable hempSMART™ team members have effectively increased the Company’s footprint into the compelling European market,” said Mr. Steinberg.

The Brightfield Group, a predictive market intelligence firm focused on the legal CBD and cannabis industries, opined on March 26, 2019, that the European CBD market was estimated at $318 million in 2018 and is expected to grow over 400 percent by 2023. Brightfield’s assessment was based on its opinion that CBD is just starting to take hold in Europe, and presents a great opportunity for developed brands to enter and expand into.

About Marijuana Company of America, Inc.
MCOA is a corporation that participates in (1) product research and development of legal hemp-based consumer products under the brand name hempSMART™, which targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward-Looking Statements
This news release contains “forward-looking statements” that are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities, and words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Contact:
[email protected]
888-777-4362

Corporate Communications Contact: 
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office 
[email protected]

For more information, please visit the Company’s websites at:
MarijuanaCompanyofAmerica.com
hempSMART.com

Marijuana Company of America $MCOA Announces Successful Launch of hempSMART™ CBD Product Sales in Scotland $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:46 AM on Wednesday, June 26th, 2019
15233 mcoa
  • Announced that the Company’s wholly owned subsidiary, hempSMART, Ltd., has successfully launched and generated sales from its hempSMART™ CBD product line in Scotland.
  • On June 22, 2019, the hempSMART UK team successfully sold out at its launch event, which led to the sign-up of numerous new marketing associates.

ESCONDIDO, Calif., June 26, 2019 – - MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTCQB: MCOA), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s wholly owned subsidiary, hempSMART, Ltd., has successfully launched and generated sales from its hempSMART™ CBD product line in Scotland.

On June 22, 2019, the hempSMART UK team successfully sold out at its launch event, which led to the sign-up of numerous new marketing associates. The Company’s launch event included an in-depth overview on the education of the CBD industry and its hempSMART products, as well as its marketing and compensation plans.

“We are delighted to report another milestone with the opening of hempSMART and our expansion into Scotland,” said Mr. Ian Harvey, Global Sales Director of hempSMART, Ltd. “There is a real demand for high-quality CBD products throughout Europe, and the success demonstrated from our sales in Scotland has confirmed this. After Saturday’s event, Scotland is an ideal location for the hempSMART brand, with future events and opportunity presentations already in place. I personally didn’t expect to ever be a part of a new company that could generate so much success and excitement in such a short period of time.”

“We are excited to finally offer our premium line of CBD products to the country of Scotland,” said Mr. Don Steinberg, CEO of MCOA. “It has always been MCOA’s goal to open sales of its hempSMART products in multiple countries around the world. Our Company anticipates additional expansions of our footprint into other EU countries moving into the second half of 2019.”

About Marijuana Company of America, Inc.
MCOA is a corporation that participates in (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™â€ and targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements
This news release contains “forward-looking statements” that are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan” or similar phrases that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Contact:
[email protected]
888-777-4362
Corporate Communications Contact: 
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com 
212.418.1217 Office 
[email protected] 

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA 

Bougainville Ventures $BOG.ca Begins Planting its Oregon #Hemp Farm & Begins Construction of Drying Facility $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 7:09 AM on Tuesday, June 25th, 2019
681747 5720 copy 2
  • Signed definitive agreement that completed the acquisition of Worm Castings Transaction, management is pleased to announce that the 10 acre hemp farm is currently being planted. 
  • The hemp farm in Oregon has a crew of 20 persons planting 28,000 plants and finalizing the laying of mulch and drip lines that will be completed by the end of the week.

VANCOUVER, British Columbia, June 25, 2019 – BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE: BOG) (8BV-FF:Frankfurt Stock Exchange) – Further to the Company’s news release dated May 23, 2019, announcing the signed definitive agreement that completed the acquisition of Worm Castings Transaction, management is pleased to announce that the 10 acre hemp farm is currently being planted. 

Worm Castings is the owner of a Oregon State Hemp production and processing license, issued by the Oregon State Regulatory approval board. The hemp farm in Oregon has a crew of 20 persons planting 28,000 plants and finalizing the laying of mulch and drip lines that will be completed by the end of the week. The genetics being used are premium high quality cloned hemp plants with 10-15% CBD and 0.3% THC resulting in maximized CBD oil content within each plant. In addition, all plants grown on the farm will be pesticide and chemical free with a proven top soil mix that will increase plant growth by 20%.

Worm Casting anticipates building its 5,000 sq. ft. facility with a full spectrum of extract equipment, for distillate and isolate as the key end ingredient. The processing plant is expected to be operational by fourth quarter of this year. The foundation for the drying facility has been built and management is in contact with all parties involved in setting up the drying and lab equipment.

Bougainville believes that Worm Castings state-of-the-art future facility combined with its experienced management team will grow its hemp business significantly in 2019. Management will be considering a name change from Worm Casting Farms Inc., to better reflects its hemp CBD processing facility. Also, subject to board approval the Company plans to invest up to USD$1,000,000 to expand the capacity of the infrastructure, and working capital.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5e82548b-931e-44fb-8b68-8846f5e529f0

Andy Jagpal, President, Comments:
“This is an exciting time for our Company as we are almost done planting for our 2019 hemp season. Once the construction of our drying facility and processing plant is completed partnership with other local farmers can begin. By processing not only our crop but others as well, we can maximize profits and financial returns for our shareholders. Also, we have yet to process the 15,000lbs of un-dried hemp biomass from last year’s harvest, which has an estimated value of $300,000 USD once processed.”

About Bougainville Ventures, Inc.  
Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids in both Canada and the United States. Along with our flagship Hemp project in Oregon State and the Greenhouse campus in Washington state, the Company has proprietary formulas for cannabis edibles, topical, and tinctures.

More pictures of the planting process and construction of the processing facility can be viewed at:
http://bougainvilleinc.com/ 

https://twitter.com/bougainvilleinc

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC.

Andy Jagpal, CEO and Director

For further information, please contact Andy Jagpal at [email protected]. Please note that our Toll free number has changed to 1-877-517-7816.

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

Oregon Hemp Farm

Bougainville Ventures Inc $BOG.ca – Ontario #cannabis sales more than doubled after stores started to open #weed $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 9:00 PM on Monday, June 24th, 2019
SPONSOR:  Bougainville Ventures Inc (CSE: BOG) Converting irrigated farmland to greenhouse-equipped farmland. Bougainville does not “touch the plant” and only provides agricultural infrastructure as a landlord for licensed marijuana growers. Click here for more info.
BOG:CSE
—————————————

Ontario cannabis sales more than doubled after stores started to open

  • Under the online system, sales ranged between $7 million and $8 million a month.
  • With even a few stores opening, that number quickly soared, reaching $19.6 million for April.

Legal cannabis sales more than doubled in Ontario in April, after stores started to open, data released Friday by Statistics Canada shows.

Ontario was the only province to only offer online cannabis sales until April 1, when a handful of stores opened.

Under the online system, sales ranged between $7 million and $8 million a month. With even a few stores opening, that number quickly soared, reaching $19.6 million for April.

On a per capita basis, Ontarians spent between 50 and 60 cents a month on legal cannabis from December through March, but $1.36 in April.

That still puts Ontario’s per capita cannabis sales at the second-lowest in Canada (in terms of dollars spent, Ontario sales are now Canada’s highest, passing Quebec and Alberta in April).

Ontario had a much slower rollout of legal stores than other provinces. The previous Liberal government had planned for a network of government-run stores similar to the province’s liquor store network. That plan had made some progress before an incoming PC government changed plans to one based on privately owned stores with the owners selected by lottery.

The first of a group of 25 stores opened in April, though not all of those who won the lottery were in a position to open on April 1.

Canadians happily buy clothes, books and diapers online. But as the sales figures show, they strongly prefer to buy weed in person at stores — and if they can’t, they keep their money in their pockets.

Why is that?

Experts we talked to said it’s important to people to be able to see and smell the product. And new or returning users may want to get advice and information from a real person at a store.

“People want to be able to understand, from people they can trust, how this is going to taste and feel, and how it will make them feel.” said Deepak Anand, CEO of Materia Ventures, a cannabis supply and distribution company.

But one of the most important things was the ability to use cash.

“You have to share your ID in a store, but one you’ve done that, there’s no record of you having been there,” said Brock University business professor Michael Armstrong. “You could pay in cash and walk out the door with your plain paper bag.”

A majority of Canadian cannabis consumers fear their use, legal or not, will cause them problems crossing the U.S. border.

In December, the federal privacy commissioner urged Canadians to buy their weed with cash if that concerned them.

“The personal information of cannabis users is … very sensitive,” the statement said. “For example, some countries may deny entry to individuals if they know they have purchased cannabis, even lawfully.”

Source: https://globalnews.ca/news/5424432/ontario-cannabis-sales-stores-open/

CLIENT FEATURE: $APPB Prior Chief Medical Officer and Senior Director of Oncology Research and Development with Pfizer Inc. appointed APPB CEO $PFE $WMD.ca $CGRW $APH.ca $GBLX $ACG.ca $ACB.ca $WEED.ca $HIP.ca

Posted by AGORACOM at 1:17 PM on Thursday, June 13th, 2019
  • Dr. Raymond  W. Urbanski MD, PhD, will work closely with the Board of Directors to set the vision and strategic direction of the company
  • Will establish organizational structure, processes and key hires necessary to continue the growth of Applied BioSciences. 
  • Overseeing the development of key products in the Applied BioSciences’ product pipeline
  • Directing development within the newly formed Applied BioPharma Division which is focused on innovative cannabinoid therapies being developed to address the unmet medical needs of patients across multiple therapeutic areas.

About Applied BioSciences Corp.
Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries.  The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.
Trace Analytics Inc. is a leading cannabis science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology.  The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected]  or [email protected] Official Website: www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

Link to AppliedBioSciences Hub

FULL DISCLOSURE: Applied BioSciences is an advertising client of AGORA Internet Relations Corp

Bougainville Ventures $BOG.ca and ESEV R&D Begins Formulation Process for CBD Energy Drink $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 8:41 AM on Thursday, June 13th, 2019
681747 5720 copy 2
  • Further to the Israeli sponsorship research agreement announced in the Company’s news release dated May 14, 2019, management is pleased to announce that it has paid a 10% deposit to ESEV R&D to begin the formulations process on the water soluble cannabis-based (CBD) supplement energy drink
  • The final report will include; clinical trials results, sourcing of ingredients, PH balance, nutritional chart, shelf-life, as well as cost of ingredients and contacts.

VANCOUVER, British Columbia, June 13, 2019 – BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE:BOG) (Frankfurt:8BV)Further to the Israeli sponsorship research agreement announced in the Company’s news release dated May 14, 2019, management is pleased to announce that it has paid a 10% deposit to ESEV R&D to begin the formulations process on the water soluble cannabis-based (CBD) supplement energy drink. The final report will include; clinical trials results, sourcing of ingredients, PH balance, nutritional chart, shelf-life, as well as cost of ingredients and contacts.

Andy Jagpal, President, Comments:“We have already begun sourcing a local bottling company to handle the production and processing of the CBD energy drink once the formulations are ready. We are adamant about bringing the energy drink formulation to market and feel we have developed the right relationships to get the job done right.”

WORMCASTING TRANSACTION FINANCING UPDATE

Further to the Company news release dated June 11, 2019, management is pleased to announce that it has paid-off the final outstanding payment of USD$120,000 owed to Worm Castings Farms Inc. pursuant to Bougainville’s obligation under the Worm Castings Share Exchange Agreement.

OROVILLE CAMPUS UPDATE

Further to the Company news release dated April 1, 2019, management would like to announce that the tenant grower is waiting to receive final occupancy approval from the Washington State Liquor and Cannabis Board (“WSLCB”) to begin planting. The tenant expects a visit to the site by the WSLC in the near future and is planning to plant a 20,000 sq. ft. out-door crop.

In addition, the Company wishes to correct an error in its news release dated May 1, 2019 in which the Company announced that a private placement with gross proceeds of $190,000 for 3,166,666 Units at a price of $0.06 per Unit (the “Private Placement”) had closed. The Private Placement was oversubscribed for 3,316,666. The remainder of the news release dated May 1, 2019 is accurate and the oversubscribed Private Placement was closed on May 1, 2019 with the amount of $199,000 for 3,316,666 Units

About Bougainville Ventures, Inc.  
Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids (CBD & CBN) in both Canada and the United States. With our flagship Hemp project in Oregon State the Company has proprietary, patent-pending hemp root oil extraction technology and formulas for cannabis topicals and tinctures.

http://bougainvilleinc.com/

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC.

Andy Jagpal, CEO and Director

For further information, please contact Andy Jagpal at [email protected] or 1-888-395-7816 

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

Bougainville Ventures Inc. $BOG.ca Enters in to Funding and Asset Purchase Agreement with Island Biopharma Inc. $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 7:18 AM on Tuesday, June 11th, 2019
681747 5720 copy 2
  • Signed a letter of intent (LOI) to provide funding and to acquire 100% of the assets and inventory of Island Biopharma Inc.
  • Biopharma has developed a dedicated line of Cannabidiols products which a include proprietary CBD blended tincture product with three specific recipes for anxiety, energy and sleep.

VANCOUVER, British Columbia, June 11, 2019 — BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE:BOG) is pleased to announce that it has signed a letter of intent (LOI) to provide funding and to acquire 100% of the assets and inventory of Island Biopharma Inc.(Biopharma). Biopharma has developed a dedicated line of Cannabidiols (“CBD”) products which a include proprietary CBD blended tincture product with three specific recipes for anxiety, energy and sleep.

LOI Terms

Subject to Board approval from the Company and completion of satisfactory due diligence, the parties intend to enter into a definitive agreement on or before June 30, 2019. The Company will acquire 100% of Biopharma assets and current inventory. The consideration is to be payable in such number of common shares in its share capital (“Consideration Shares”) at a per share price equal to the volume weighted average price of such shares on the Canadian Securities Exchange over a 15-day period ending on the day such Consideration Shares are required to be issued (“15 day VWAP”). In addition, Biopharma will contribute operational expertise, exclusive licenses for products marketed in North America supported by an intellectual property licensing agreement, and exclusivity for all current and future technology for oil extraction in North America. The final evaluation will be determined by an independent third party evaluator, which is currently in progress.

Assets include:

  • Proprietary Formulas for Anxiety, Energy and Sleep
  • Lab Reports
  • All Proprietary Information

About Island Biopharma Inc.

Biopharma possesses a CBD blended tincture product with three specific recipes for anxiety, energy and sleep. The philosophy of Biopharma is to create products using the highest quality of bio-active ingredients, and oil extraction methods that preserve the essence of the cannabis plant. Biopharma has studied plant genetics for their therapeutic effects by incorporating modern research techniques and by analyzing the healing and therapeutic benefits of each strain giving the company a huge range of combinations and therapeutic benefits for specific ailments.

According to an estimate from cannabis industry analysts the hemp-CBD market alone could hit $22 billion by 2022. CBD can be used to effectively treat epilepsy, anxiety, insomnia and chronic pain. The Island Biopharma CBD line is designed to harness the healing power of cannabis without the psychotropic effects of tetrahydrocannabinol (“THC”).

CEO, Andy Jagpal Comments: 
“This marks an exciting step forward for our brand’s expansion into multiple CBD products. The acquisition of Island Biopharma will contribute greatly to our future product lines. With the development of our CBD infused energy drink already in development this acquisition will complement our goal of producing high quality proven cannabaniod products. This is in-line with the anticipated launch of the Canadian cannabis legislation bringing about the legalization of the edible market slated for the fall of 2019”.  

WORMCASTING TRANSACTION FINANCING UPDATE

Further to the Form 45-102F1 Notice of Intention to Distribute Securities filed May 22, 2019 and associated news release dated May 24, 2019 the Company announces that management has sold a total of 1,000,000 shares of (BOG:CSE) with proceeds of $CAD100,000. These proceeds have been contributed towards the final outstanding payment of $USD120,000 owed to Worm Castings pursuant to Bougainville’s obligation under the Worm Castings Transaction announced in the Company’s news release dated May 23, 2019. Management continues to defer salaries as it has for the past two years to help conserve working capital to enable the company to reach its milestones.

About Bougainville Ventures, Inc.  
Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids (CBD & CBN) in both Canada and the United States. With our flagship Hemp project in Oregon State the Company has proprietary, patent-pending hemp root oil extraction technology and formulas for cannabis topicals and tinctures.

http://bougainvilleinc.com/

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC.

Andy Jagpal, CEO and Director

For further information, please contact Andy Jagpal at [email protected] or 1-844-734-8420 

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release. Source: GlobeNewswire (June 11, 2019 – 3:00 AM EDT)

News by QuoteMedia
www.quotemedia.com

INTERVIEW: Vertical Exploration $VERT Discusses Wollastonite Which Is Proving To Be a Critical Tool for Cannabis Crop Protection and Enhancement $TORR.ca $FA.ca

Posted by AGORACOM-JC at 9:43 AM on Monday, June 10th, 2019

Joining us on this episode is Peter P. Swistak, President/CEO of Vertical Exploration.

The company has recently received positive results from its Phase 1 Research and Development program that was conducted by AGRINOVA using wollastonite from the Company’s St-Onge deposit. All of the research and testing in the Phase 1 program was managed and monitored by AGRINOVA, a highly-regarded Center for Research and Innovation in Agriculture in Quebec, in an effort to optimize the potential agricultural uses of wollastonite and help improve production methods for farmers and agricultural companies located in Quebec.

Applied Biosciences $APPB Launches Champ Organics CBD Product Line with Boxing Heavyweight Champion Shannon Briggs $PFE $WMD.ca $CGRW $APH.ca $GBLX $ACG.ca $ACB.ca $WEED.ca $HIP.ca

Posted by AGORACOM at 11:51 AM on Thursday, June 6th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png

Los Angeles, CA, June 06, 2019 (GLOBE NEWSWIRE) — Applied Biosciences Corp. (OTC: APPB), a vertically integrated company focused on the development of science-driven cannabinoid therapeutics and biopharmaceuticals, announced that has officially launched its Champ Organics product line with Shannon “the Cannon” Briggs, the former heavyweight boxing champion and world record-holder for the most first-round knockouts.

The product line was created to formulate a line of athlete-focused cannabidiol (“CBD”) based health and wellness supplements to enhance training and recovery under the “Champ Organics” brand.

The initial product launch includes CBD Isolate Infused MCT Soft Gels and Tinctures, Full Spectrum CBD Oil Infused Topicals and Nano CBD Infused Natural Beverage Shots and Spring Water. “Utilizing the most effective, natural methods to offer CBD in bioavailable blends, Champ Organics Soft Gels and Tinctures are based in Organic MCT. The All-Natural Topical Blends have been crafted to carry Full-Spectrum CBD Oil safely and effectively through the skin, while leaving a comfortable and clean feeling on the skin. Additionally, pure CBD Isolate is processed into Nano CBD molecules and infused into amazing all-natural blends used in the Champ Organics Shots, along with the Spring Water,” stated J.J. Southard, Vice President of Applied BioSciences.

Additionally, Briggs and the Company will collaborate on an awareness campaign to help educate athletes around the world about the potential benefits of using CBD for pain management, relaxation, decreasing anxiety and improving sleep quality.  Briggs hopes to educate the general public on the potential benefits of using CBD to help decrease dependence on opioids.

“I have partnered with Applied BioSciences to develop and market Champ Organics because their products are made with the highest quality ingredients and all-natural CBD.  I am a firm believer in the benefits that CBD delivers for joint pain and headaches. Since I have incorporated CBD to my daily supplements, I have been surprised by the positive impact it has had on my overall quality of life.” commented Shannon Briggs

“The all-natural formulations of Applied Biosciences’ CBD products attracted Briggs to our Company,” commented Chris Bridges, President, and Director of Applied Biosciences. “This is another step in our company’s aligned mission to create organic health and wellness products.  This partnership will allow us to expand into a new vertical and additional distribution channels globally.”

About Applied BioSciences Corp.

Applied BioSciences Corp. (www.appliedbiocorp.com), is a vertically integrated company focused on the development of science-driven cannabinoid therapeutics and biopharmaceuticals, as well as state-of-the-art testing and analytics capabilities to our customers.  As a leading company in the CBD, Pet and Health and Wellness space, the company is currently shipping to the majority of US states as well as to 5 International countries

ContactEmail:

[email protected]  or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com 

Brands:

www.remedishop.com

www.herbalpet.com

www.champorganics.com

Follow us:

Facebook @remediplus & @HerbalPetMeds & @Champ-Organics

Instagram @remediplus & @herbal_pet & @champorganics

Twitter @remediplus & @herbal_pet & @ChampOrganics